collection
https://read.qxmd.com/read/38084984/effectiveness-of-prophylactic-oral-and-or-vaginal-probiotic-supplementation-in-the-prevention-of-recurrent-urinary-tract-infections-a-randomized-double-blind-placebo-controlled-trial
#1
JOURNAL ARTICLE
Varsha Gupta, Paola Mastromarino, Ritu Garg
BACKGROUND: Widespread antibiotic resistance has sparked interest in the lookout for non-antibiotic strategies, particularly focusing on probiotics for the prevention of recurrent urinary tract infections (UTIs). We evaluated the effectiveness of prophylactic probiotic supplementation through oral and intravaginal routes in the prevention of recurrent UTIs. METHODS: This double-blind, placebo-controlled study enrolled 174 premenopausal women with a history of recurrent UTIs and randomized them to either of the four treatment groups, namely, Placebo (G1, oral placebo+vaginal placebo); Oral probiotic (G2, oral lactic acid bacteria and bifidobacteria+vaginal placebo); Vaginal probiotic (G3, oral placebo+vaginal lactobacilli); and Probiotic combination (oral lactic acid bacteria and bifidobacteria+vaginal lactobacilli), for 4 months...
December 12, 2023: Clinical Infectious Diseases
https://read.qxmd.com/read/37487152/a-new-global-definition-of-acute-respiratory-distress-syndrome
#2
JOURNAL ARTICLE
Michael A Matthay, Yaseen Arabi, Alejandro C Arroliga, Gordon Bernard, Andrew D Bersten, Laurent J Brochard, Carolyn S Calfee, Alain Combes, Brian M Daniel, Niall D Ferguson, Michelle N Gong, Jeffrey E Gotts, Margaret S Herridge, John G Laffey, Kathleen D Liu, Flavia R Machado, Thomas R Martin, Danny F McAuley, Alain Mercat, Marc Moss, Richard A Mularski, Antonio Pesenti, Haibo Qiu, Nagarajan Ramakrishnan, Marco Ranieri, Elisabeth D Riviello, Eileen Rubin, Arthur Slutsky, B Taylor Thompson, Theogene Twagirumugabe, Lorraine B Ware, Katherine D Wick
BACKGROUND: Since the 2012 Berlin Definition of the Acute Respiratory Distress Syndrome (ARDS), several developments have supported the need for an expansion of the definition, including the use of high flow nasal oxygen (HFNO), expanding use of pulse oximetry in place of arterial blood gases, use of ultrasound for chest imaging, and the need for applicability in resource-limited settings. METHODS: A Consensus Conference of 32 critical care ARDS experts was convened, had six virtual meetings (June 2021-March 2022), and subsequently obtained input from members of several critical care societies...
July 24, 2023: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/34533581/interpreting-sars-cov-2-test-results
#3
JOURNAL ARTICLE
K C Coffey, Daniel J Diekema, Daniel J Morgan
No abstract text is available yet for this article.
October 19, 2021: JAMA
https://read.qxmd.com/read/34192432/cerebral-venous-thrombosis
#4
REVIEW
Allan H Ropper, Joshua P Klein
New England Journal of Medicine, Volume 385, Issue 1, Page 59-64, July 2021.
July 1, 2021: New England Journal of Medicine
https://read.qxmd.com/read/34108243/autoimmune-encephalitis-clinical-spectrum-and-management
#5
REVIEW
Christopher E Uy, Sophie Binks, Sarosh R Irani
Autoimmune encephalitis defines brain inflammation caused by a misdirected immune response against self-antigens expressed in the central nervous system. It comprises a heterogeneous group of disorders that are at least as common as infectious causes of encephalitis. The rapid and ongoing expansion of this field has been driven by the identification of several pathogenic autoantibodies that cause polysymptomatic neurological and neuropsychiatric diseases. These conditions often show highly distinctive cognitive, seizure and movement disorder phenotypes, making them clinically recognisable...
October 2021: Practical Neurology
https://read.qxmd.com/read/33716928/antiplatelet-therapy-in-the-secondary-prevention-of-non-cardioembolic-ischemic-stroke-and-transient-ischemic-attack-a-mini-review
#6
REVIEW
Martin Vališ, Blanka Klímová, Michal Novotný, Roman Herzig
The aim of this mini-review is to discuss the main antiplatelet agents that have been successfully used in the secondary prevention of non-cardioembolic ischemic stroke and transient ischemic attacks (TIA). The methodology is based on a literature review of available peer-reviewed English studies listed in PubMed. The findings reveal that aspirin remains a reliable antiplatelet agent in the secondary prevention of acute non-cardioembolic ischemic stroke and TIA. Nevertheless, currently, there are also other agents, i...
2021: Frontiers in Neurology
https://read.qxmd.com/read/33664203/update-on-the-management-of-status-epilepticus
#7
REVIEW
Andrea O Rossetti, Vincent Alvarez
PURPOSE OF REVIEW: Randomized controlled trials investigating the initial pharmacological treatment of status epilepticus have been recently published. Furthermore, status epilepticus arising in comatose survivors after cardiac arrest has received increasing attention in the last years. This review offers an updated assessment of status epilepticus treatment in these different scenarios. RECENT FINDINGS: Initial benzodiazepines underdosing is common and correlates with development of status epilepticus refractoriness...
April 1, 2021: Current Opinion in Neurology
https://read.qxmd.com/read/33674412/new-onset-refractory-status-epilepticus-norse
#8
REVIEW
Laura Mantoan Ritter, Lina Nashef
New-onset refractory status epilepticus and its subcategory febrile infection-related epilepsy syndrome are rare devastating clinical presentations in those without pre-existing relevant history, often in schoolchildren or young adults, without a clear cause on initial investigations. A cause is later identified in up to half of adults, but in many fewer children. Patients often require protracted intensive care and are at significant risk of dying. Functional disability is common and subsequent chronic epilepsy is the norm, but some people do have good outcomes, even after prolonged status epilepticus...
March 5, 2021: Practical Neurology
https://read.qxmd.com/read/33575952/management-of-musculoskeletal-pain-an-update-with-emphasis-on-chronic-musculoskeletal-pain
#9
REVIEW
Salah N El-Tallawy, Rohit Nalamasu, Gehan I Salem, Jo Ann K LeQuang, Joseph V Pergolizzi, Paul J Christo
Musculoskeletal pain is a challenging condition for both patients and physicians. Many adults have experienced one or more episodes of musculoskeletal pain at some time of their lives, regardless of age, gender, or economic status. It affects approximately 47% of the general population. Of those, about 39-45% have long-lasting problems that require medical consultation. Inadequately managed musculoskeletal pain can adversely affect quality of life and impose significant socioeconomic problems. This manuscript presents a comprehensive review of the management of chronic musculoskeletal pain...
June 2021: Pain and Therapy
https://read.qxmd.com/read/33647239/guillain-barr%C3%A3-syndrome
#10
REVIEW
Nortina Shahrizaila, Helmar C Lehmann, Satoshi Kuwabara
Guillain-Barré syndrome is the most common cause of acute flaccid paralysis worldwide. Most patients present with an antecedent illness, most commonly upper respiratory tract infection, before the onset of progressive motor weakness. Several microorganisms have been associated with Guillain-Barré syndrome, most notably Campylobacter jejuni, Zika virus, and in 2020, the severe acute respiratory syndrome coronavirus 2. In C jejuni-related Guillain-Barré syndrome, there is good evidence to support an autoantibody-mediated immune process that is triggered by molecular mimicry between structural components of peripheral nerves and the microorganism...
March 27, 2021: Lancet
https://read.qxmd.com/read/33649022/autoimmune-encephalitis-proposed-best-practice-recommendations-for-diagnosis-and-acute-management
#11
REVIEW
Hesham Abboud, John C Probasco, Sarosh Irani, Beau Ances, David R Benavides, Michael Bradshaw, Paulo Pereira Christo, Russell C Dale, Mireya Fernandez-Fournier, Eoin P Flanagan, Avi Gadoth, Pravin George, Elena Grebenciucova, Adham Jammoul, Soon-Tae Lee, Yuebing Li, Marcelo Matiello, Anne Marie Morse, Alexander Rae-Grant, Galeno Rojas, Ian Rossman, Sarah Schmitt, Arun Venkatesan, Steven Vernino, Sean J Pittock, Maarten J Titulaer
The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmune encephalitis as a broad category rather than focusing on individual antibody syndromes. Core authors from the Autoimmune Encephalitis Alliance Clinicians Network reviewed literature and developed the first draft. Where evidence was lacking or controversial, an electronic survey was distributed to all members to solicit individual responses...
July 2021: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/33630769/cerebral-small-vessel-disease-and-vascular-cognitive-impairment-from-diagnosis-to-management
#12
REVIEW
Maria Clara Zanon Zotin, Lukas Sveikata, Anand Viswanathan, Pinar Yilmaz
PURPOSE OF REVIEW: We present recent developments in the field of small vessel disease (SVD)-related vascular cognitive impairment, including pathological mechanisms, updated diagnostic criteria, cognitive profile, neuroimaging markers and risk factors. We further address available management and therapeutic strategies. RECENT FINDINGS: Vascular and neurodegenerative pathologies often co-occur and share similar risk factors. The updated consensus criteria aim to standardize vascular cognitive impairment (VCI) diagnosis, relying strongly on cognitive profile and MRI findings...
April 1, 2021: Current Opinion in Neurology
https://read.qxmd.com/read/33609465/treatment-of-asymptomatic-carotid-stenosis
#13
COMMENT
J David Spence
No abstract text is available yet for this article.
March 2021: Lancet Neurology
https://read.qxmd.com/read/33594452/risk-of-intracranial-hemorrhage-with-direct-oral-anticoagulants-a-systematic-review-and-meta-analysis-of-randomized-controlled%C3%A2-trials
#14
REVIEW
Tingting Wu, Chenyang Lv, Lishui Wu, Wenjun Chen, Meina Lv, Shaojun Jiang, Jinhua Zhang
OBJECTIVE: We performed a systematic review and meta-analysis to compare the risk of intracranial hemorrhage (ICH) between direct oral anticoagulants (DOACs) and other antithrombotic drugs in detail across all diseases. METHODS: PubMed, EMBASE, Web of Science, and the Cochrane Library were searched for relevant randomized controlled trials (RCTs). Heterogeneity was examined using the I2 statistic. Risk ratio (RR) and 95% confidence interval (CI) were calculated using random-effects meta-analysis...
February 2022: Journal of Neurology
https://read.qxmd.com/read/33600767/menstrual-migraine-a-distinct-disorder-needing-greater-recognition
#15
REVIEW
Kjersti Grøtta Vetvik, E Anne MacGregor
The term menstrual migraine refers to migraine that is associated with menstruation by more than chance, but it does not define pathophysiology. Menstrual migraine affects about 20-25% of female migraineurs in the general population, and 22-70% of patients presenting to headache clinics. In women diagnosed with menstrual migraine, perimenstrual migraine attacks are associated with substantially greater disability than their non-menstrual attacks. Loose interpretation of diagnostic criteria has led to conflicting results in studies on prevalence figures, clinical characteristics, and response to treatment...
April 2021: Lancet Neurology
https://read.qxmd.com/read/33555314/comparison-of-corticosteroid-tapering-regimens-in-myasthenia-gravis-a-randomized-clinical-trial
#16
RANDOMIZED CONTROLLED TRIAL
Tarek Sharshar, Raphaël Porcher, Sophie Demeret, Christine Tranchant, Antoine Gueguen, Bruno Eymard, Aleksandra Nadaj-Pakleza, Marco Spinazzi, Lamiae Grimaldi, Simone Birnbaum, Diane Friedman, Bernard Clair
IMPORTANCE: The tapering of prednisone therapy in generalized myasthenia gravis (MG) presents a therapeutic dilemma; however, the recommended regimen has not yet been validated. OBJECTIVE: To compare the efficacy of the standard slow-tapering regimen of prednisone therapy with a rapid-tapering regimen. DESIGN: From June 1, 2009, to July 31, 2013, a multicenter, parallel, single-blind randomized trial was conducted to compare 2 regimens of prednisone tapering...
April 1, 2021: JAMA Neurology
https://read.qxmd.com/read/33495396/the-impact-of-covid-19-on-developing-neurologic-disorders
#17
COMMENT
Piotr Tekiela, Jennifer J Majersik
No abstract text is available yet for this article.
January 26, 2021: Neurology
https://read.qxmd.com/read/33470669/current-advances-in-plasma-and-cerebrospinal-fluid-biomarkers-in-alzheimer-s-disease
#18
REVIEW
Antoine Leuzy, Nicholas C Cullen, Niklas Mattsson-Carlgren, Oskar Hansson
PURPOSE OF REVIEW: This review provides a concise overview of recent advances in cerebrospinal fluid (CSF) and blood-based biomarkers of Alzheimer's disease lesions. RECENT FINDINGS: Important recent advances for CSF Alzheimer's disease biomarkers include the introduction of fully automated assays, the development and implementation of certified reference materials for CSF Aβ42 and a unified protocol for handling of samples, which all support reliability and availability of CSF Alzheimer's disease biomarkers...
April 1, 2021: Current Opinion in Neurology
https://read.qxmd.com/read/33464762/management-of-autoimmune-encephalitis
#19
REVIEW
Christian G Bien
PURPOSE OF REVIEW: Autoimmune encephalitides are established diagnoses in contemporary neurology. Their management poses a regular challenge for almost all neurologists. One may ask if the concept of 1st line and 2nd line treatment is still up to date, which new data on the antibody-defined encephalitis types exist, and how to organize long-term management. RECENT FINDINGS: The 1st line/2nd line concept of initial immunological intervention is accepted worldwide...
April 1, 2021: Current Opinion in Neurology
https://read.qxmd.com/read/33029957/clinical-approach-to-autoimmune-epilepsy
#20
REVIEW
Yoonhyuk Jang, Dong Wook Kim, Kwang Ik Yang, Jung Ick Byun, Jong Geun Seo, Young Joo No, Kyung Wook Kang, Daeyoung Kim, Keun Tae Kim, Yong Won Cho, Soon Tae Lee
Autoimmune epilepsy is a newly emerging area of epilepsy. The concept of "autoimmune" as an etiology has recently been revisited thanks to advances in autoimmune encephalitis and precision medicine with immunotherapies. Autoimmune epilepsy presents with specific clinical manifestations, and various diagnostic approaches including cerebrospinal fluid analysis, neuroimaging, and autoantibody tests are essential for its differential diagnosis. The diagnosis is often indeterminate despite performing a thorough evaluation, and therefore empirical immunotherapy may be applied according to the judgment of the clinician...
October 2020: Journal of Clinical Neurology
label_collection
label_collection
7410
1
2
2021-01-18 07:52:49
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.